Olopatadine Hydrochloride Ophthalmic Solution: 0.1%, 0.2%, 0.7% | MedexInfo
Olopatadine Hydrochloride Ophthalmic Solution (0.1%, 0.2%, 0.7%)
Rx Only
Therapeutic ClassAntihistamine / Mast Cell Stabilizer
Common Dose1 drop in affected eye(s) once daily
PregnancyCategory C
Indications ▼
Seasonal allergic conjunctivitis: relief of ocular itching, redness, tearing, and burning sensation.
Perennial allergic conjunctivitis caused by dust, animal dander, or mold exposure.
Prevention of ocular allergy symptoms when administered prior to allergen exposure.
Mechanism & Pharmacokinetics ▼
Mechanism: Blocks H1 histamine receptors and stabilizes conjunctival mast cells, reducing histamine-mediated inflammation and ocular itching.
Pharmacokinetics: Minimal systemic absorption; peak plasma levels negligible. Metabolized hepatically; excreted via urine. Half-life not clinically significant due to topical use.
Dosage & Administration ▼
| Strength | Patient Category | Recommended Dose | Max / 24h |
|---|---|---|---|
| 0.1% (1 mg/mL) | Adults & Children ≥3 years | 1 drop in affected eye(s) twice daily | 2 drops per eye |
| 0.2% (2 mg/mL) | Adults & Children ≥3 years | 1 drop in affected eye(s) once daily | 1 drop per eye |
| 0.7% (7 mg/mL) | Adults & Children ≥3 years | 1 drop in affected eye(s) once daily | 1 drop per eye |
Side Effects ▼
Common: mild burning, stinging, eye irritation, dry eyes
Occasional: headache, blurred vision, taste perversion
Rare: hypersensitivity reactions (eye swelling, rash)
Contraindications ▼
Hypersensitivity to olopatadine or ophthalmic excipients
Active ocular infection (bacterial, viral, fungal)
Drug Interaction ▼
No clinically significant interactions reported
Use other eye drops at least 5 minutes apart
Pregnancy & Lactation ▼
Use only if clearly needed (Category C)
Minimal systemic absorption; generally compatible with breastfeeding
Clinical / Research Summary ▼
Rapid Symptom Relief: All strengths provide fast relief of ocular itching, redness, and tearing within minutes.
Once- vs Twice-Daily Dosing: 0.1% requires twice-daily dosing; 0.2% and 0.7% allow convenient once-daily dosing with comparable efficacy.
Long-Term Use: Well-tolerated in chronic allergic conjunctivitis; minimal systemic side effects reported.
Prophylactic Use: Effective for preventing symptoms when applied prior to allergen exposure.
Safety: Rare hypersensitivity reactions; no significant impact on vision or intraocular pressure observed.
Patient Counseling Points ▼
Wash hands before use; avoid touching dropper tip to eye
Follow recommended dosing frequency for the specific strength
Wait 5 minutes if using other eye drops
Remove contact lenses before administration; reinsert after 10 minutes
Report persistent irritation, redness, or vision changes
Consult physician if pregnant or breastfeeding
Storage & Handling ▼
Store at 2–25°C; protect from light; do not freeze
Keep out of reach of children
Brand Names (Bangladesh & Global) ▼
Bangladesh (Local Brands):
Global / International Brands:
Opatanol 0.1%, 0.2%, 0.7%
Patanol 0.1%, 0.2%, 0.7%
Opatanol 0.1%, 0.2%, 0.7%
Patanol 0.1%, 0.2%, 0.7%
Olopatadine 0.7%
Medical Disclaimer: This clinical summary is for informational purposes only. Always follow guidance from a qualified healthcare professional for dosage, interactions, and use.
.png)
